Literature DB >> 24292715

Napyradiomycins CNQ525.510B and A80915C target the Hsp90 paralogue Grp94.

Lauge Farnaes1, James J La Clair, William Fenical.   

Abstract

The intracellular localization and target of the napyradiomycin congeners CNQ525.510B and A80815C were explored using an immunoaffinity fluorescence (IAF) approach. Semi-synthetic methods were used to prepare probes from napyradiomycin CNQ525.510B and derivative A80815C. The results of confocal microscopy indicated that probes from both natural products localized predominantly within the endoplasmic reticulum (ER) of HCT-116 human colon carcinoma cells. Parallel immunoaffinity precipitation efforts using a monoclonal antibody designed against the IAF tag, resulted in the isolation of an Hsp90 family member. This protein was identified as human Grp94 (hGrp94), by its specific mass spectral signature. This observation was validated by Western blot analyses and by the result of an in vitro Grp94 binding assay. The fact that the napyradiomycins CNQ525.510B and A80815C bind to hGrp94, and their associated probes localize within the ER, suggest the use of these materials as molecular probes for monitoring ER-based chaperone function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24292715      PMCID: PMC3893886          DOI: 10.1039/c3ob41355a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  35 in total

1.  Ligand-induced conformational shift in the N-terminal domain of GRP94, an Hsp90 chaperone.

Authors:  Robert M Immormino; D Eric Dollins; Paul L Shaffer; Karen L Soldano; Melissa A Walker; Daniel T Gewirth
Journal:  J Biol Chem       Date:  2004-08-02       Impact factor: 5.157

2.  Napyradiomycin A1, an inhibitor of mitochondrial complexes I and II.

Authors:  Kohta Yamamoto; Etsu Tashiro; Keiichiro Motohashi; Haruo Seto; Masaya Imoto
Journal:  J Antibiot (Tokyo)       Date:  2012-01-18       Impact factor: 2.649

3.  An optimized immunoaffinity fluorescent method for natural product target elucidation.

Authors:  Wei-Luen Yu; Gianni Guizzunti; Timothy L Foley; Michael D Burkart; James J La Clair
Journal:  J Nat Prod       Date:  2010-09-13       Impact factor: 4.050

4.  Antibiotic terpenoid chloro-dihydroquinones from a new marine actinomycete.

Authors:  Irma E Soria-Mercado; Alejandra Prieto-Davo; Paul R Jensen; William Fenical
Journal:  J Nat Prod       Date:  2005-06       Impact factor: 4.050

5.  Napyradiomycin derivatives, produced by a marine-derived actinomycete, illustrate cytotoxicity by induction of apoptosis.

Authors:  Lauge Farnaes; Nicole G Coufal; Christopher A Kauffman; Arnold L Rheingold; Antonio G DiPasquale; Paul R Jensen; William Fenical
Journal:  J Nat Prod       Date:  2013-12-13       Impact factor: 4.050

6.  Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation.

Authors:  Karen L Soldano; Arif Jivan; Christopher V Nicchitta; Daniel T Gewirth
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

7.  Studies on new antibiotics SF2415. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.

Authors:  T Shomura; S Gomi; M Ito; J Yoshida; E Tanaka; S Amano; H Watabe; S Ohuchi; J Itoh; M Sezaki
Journal:  J Antibiot (Tokyo)       Date:  1987-06       Impact factor: 2.649

8.  Novel antibiotics napyradiomycins. Production, isolation, physico-chemical properties and biological activity.

Authors:  K Shiomi; H Iinuma; M Hamada; H Naganawa; M Manabe; C Matsuki; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1986-04       Impact factor: 2.649

9.  Enantioselective total synthesis of (-)-napyradiomycin A1 via asymmetric chlorination of an isolated olefin.

Authors:  Scott A Snyder; Zhen-Yu Tang; Ritu Gupta
Journal:  J Am Chem Soc       Date:  2009-04-29       Impact factor: 15.419

Review 10.  Geldanamycin and its derivatives as Hsp90 inhibitors.

Authors:  Magdalena Gorska; Urszula Popowska; Alicja Sielicka-Dudzin; Alicja Kuban-Jankowska; Wojciech Sawczuk; Narcyz Knap; Giuseppe Cicero; Fabio Wozniak
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01
View more
  9 in total

1.  Ritterostatin GN 1N , a Cephalostatin-Ritterazine Bis-steroidal Pyrazine Hybrid, Selectively Targets GRP78.

Authors:  Andrew J Ambrose; Evelyne A Santos; Paula C Jimenez; Danilo D Rocha; Diego V Wilke; Paolo Beuzer; Josh Axelrod; Ananda Kumar Kanduluru; Philip L Fuchs; Hu Cang; Letícia V Costa-Lotufo; Eli Chapman; James J La Clair
Journal:  Chembiochem       Date:  2017-02-02       Impact factor: 3.164

2.  Seriniquinone, a selective anticancer agent, induces cell death by autophagocytosis, targeting the cancer-protective protein dermcidin.

Authors:  Lynnie Trzoss; Takashi Fukuda; Letícia V Costa-Lotufo; Paula Jimenez; James J La Clair; William Fenical
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-30       Impact factor: 11.205

3.  Single dish gradient screening of small molecule localization.

Authors:  Paolo Beuzer; Joshua Axelrod; Lynnie Trzoss; Willam Fenical; Ramesh Dasari; Antonio Evidente; Alexander Kornienko; Hu Cang; James J La Clair
Journal:  Org Biomol Chem       Date:  2016-08-17       Impact factor: 3.876

4.  The Hybrid Pyrroloisoindolone-Dehydropyrrolizine Alkaloid (-)-Chlorizidine A Targets Proteins within the Glycolytic Pathway.

Authors:  Xavier Álvarez-Micó; Danilo D Rocha; Larissa A Guimarães; Andrew Ambrose; Eli Chapman; Leticia V Costa-Lotufo; James J La Clair; William Fenical
Journal:  Chembiochem       Date:  2015-08-12       Impact factor: 3.164

Review 5.  Lessons in Organic Fluorescent Probe Discovery.

Authors:  Sachin B Wagh; Vladimir A Maslivetc; James J La Clair; Alexander Kornienko
Journal:  Chembiochem       Date:  2021-06-23       Impact factor: 3.164

Review 6.  Bacterial terpenome.

Authors:  Jeffrey D Rudolf; Tyler A Alsup; Baofu Xu; Zining Li
Journal:  Nat Prod Rep       Date:  2021-05-26       Impact factor: 15.111

Review 7.  Broad targeting of resistance to apoptosis in cancer.

Authors:  Ramzi M Mohammad; Irfana Muqbil; Leroy Lowe; Clement Yedjou; Hsue-Yin Hsu; Liang-Tzung Lin; Markus David Siegelin; Carmela Fimognari; Nagi B Kumar; Q Ping Dou; Huanjie Yang; Abbas K Samadi; Gian Luigi Russo; Carmela Spagnuolo; Swapan K Ray; Mrinmay Chakrabarti; James D Morre; Helen M Coley; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; William G Helferich; Xujuan Yang; Chandra S Boosani; Gunjan Guha; Dipita Bhakta; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; W Nicol Keith; Alan Bilsland; Dorota Halicka; Somaira Nowsheen; Asfar S Azmi
Journal:  Semin Cancer Biol       Date:  2015-04-28       Impact factor: 15.707

8.  MDN-0170, a New Napyradiomycin from Streptomyces sp. Strain CA-271078.

Authors:  Rodney Lacret; Ignacio Pérez-Victoria; Daniel Oves-Costales; Mercedes de la Cruz; Elizabeth Domingo; Jesús Martín; Caridad Díaz; Francisca Vicente; Olga Genilloud; Fernando Reyes
Journal:  Mar Drugs       Date:  2016-10-18       Impact factor: 5.118

9.  New Napyradiomycin Analogues from Streptomyces sp. Strain CA-271078.

Authors:  Daniel Carretero-Molina; Francisco Javier Ortiz-López; Jesús Martín; Daniel Oves-Costales; Caridad Díaz; Mercedes de la Cruz; Bastien Cautain; Francisca Vicente; Olga Genilloud; Fernando Reyes
Journal:  Mar Drugs       Date:  2019-12-26       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.